Author
Listed:
- Tianhao Chu
(Fudan University, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education
Chinese Academy of Medical Sciences)
- Guiqi Zhu
(Fudan University, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education
Chinese Academy of Medical Sciences)
- Zheng Tang
(Fudan University, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education
Chinese Academy of Medical Sciences)
- Weifeng Qu
(Fudan University, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education
Chinese Academy of Medical Sciences)
- Rui Yang
(Fudan University, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education
Chinese Academy of Medical Sciences)
- Haiting Pan
(Fudan University)
- Yi Wang
(Fudan University, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education
Chinese Academy of Medical Sciences)
- Ruilin Tian
(Shanghai Medical College of Fudan University)
- Leilei Chen
(Shanghai Medical College of Fudan University)
- Zhiqi Guan
(Fudan University, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education
Chinese Academy of Medical Sciences)
- Yichao Bu
(Fudan University, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education
Chinese Academy of Medical Sciences)
- Qianfu Zhao
(Fudan University, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education
Chinese Academy of Medical Sciences)
- Jiafeng Chen
(Fudan University, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education
Chinese Academy of Medical Sciences)
- Shengwei Mao
(Fudan University, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education
Chinese Academy of Medical Sciences)
- Yuan Fang
(Fudan University, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education
Chinese Academy of Medical Sciences)
- Jun Gao
(Fudan University, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education
Chinese Academy of Medical Sciences)
- Xiaoling Wu
(Fudan University, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education
Chinese Academy of Medical Sciences)
- Jian Zhou
(Fudan University, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education
Chinese Academy of Medical Sciences)
- Weiren Liu
(Fudan University, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education
Chinese Academy of Medical Sciences)
- Dan Ye
(Shanghai Medical College of Fudan University)
- Jia Fan
(Fudan University, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education
Chinese Academy of Medical Sciences)
- Yinghong Shi
(Fudan University, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education
Chinese Academy of Medical Sciences)
Abstract
The functional programs adopted by cancer cells and their impact on the tumor microenvironment are complex and remain unclear. Here, we identify three distinct single-cell archetypes (i.e. metabolism, stemness and inflammation) in hepatocellular carcinoma (HCC) cells, each exhibiting unique spatial distribution. Further analysis shows an immune-suppressive niche populated by metabolism archetype cancer cells and TREM2-positive tumor-associated macrophages (TREM2+ TAMs), which exacerbates immune exclusion and compromises patient outcomes. Mechanistically, we demonstrate that the upregulated squalene epoxidase (SQLE) expression in metabolism archetype cancer cells facilitates the generation of oxidized LDL (oxLDL). OxLDL induces TREM2+ TAM polarization through the TREM2-SYK-CEBPα axis, enabling these TAMs to promote cancer cell invasion, resistance to effector cytokines and CD8+ T cell dysfunction. Importantly, cancer cell-intrinsic SQLE and TREM2+ TAMs are associated with inferior immunotherapy response in human and mouse HCC. Our results highlight an oxLDL-mediated metabolic interplay between cancer cells and TREM2+ TAMs, offering a promising therapeutic avenue for HCC immunotherapies.
Suggested Citation
Tianhao Chu & Guiqi Zhu & Zheng Tang & Weifeng Qu & Rui Yang & Haiting Pan & Yi Wang & Ruilin Tian & Leilei Chen & Zhiqi Guan & Yichao Bu & Qianfu Zhao & Jiafeng Chen & Shengwei Mao & Yuan Fang & Jun , 2025.
"Metabolism archetype cancer cells induce protumor TREM2+ macrophages via oxLDL-mediated metabolic interplay in hepatocellular carcinoma,"
Nature Communications, Nature, vol. 16(1), pages 1-25, December.
Handle:
RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-62132-y
DOI: 10.1038/s41467-025-62132-y
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-62132-y. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.